Lung cancer UPDATE || Public Health Genomics Knowledge Base (v1.2) :: August 11-18, 2016

Public Health Genomics Knowledge Base (v1.2)



August 11-18, 2016 




Last Updated: Aug 11, 2016

• A Cost-Effectiveness Analysis of Using the JBR.10-Based 15-Gene Expression Signature to Guide Adjuvant Chemotherapy in Early Stage Non-Small-Cell Lung Cancer.
  Wong Kit Man et al. Clinical lung cancer 2016 Jul
• Implementation and Quality Control of Lung Cancer EGFR Genetic Testing by MALDI-TOF Mass Spectrometry in Taiwan Clinical Practice.
  Su Kang-Yi et al. Scientific reports 2016 630944
• Long telomeres and cancer risk among 95 568 individuals from the general population.
  Rode Line et al. International journal of epidemiology 2016 Aug
• Rapid Intracranial Response to Osimertinib in a Patient with Epidermal Growth Factor Receptor T790M-Positive Adenocarcinoma of the Lung.
  Reichegger Hermann, et al. Oncology research and treatment 2016 0 (7-8) 461-3
• Retraction Note to: Meta-analysis of the associations between TNF-? or IL-6 gene polymorphisms and susceptibility to lung cancer.
  Zhou Wei, et al. European journal of medical research 0 0 (1) 31
• The breast cancer susceptibility-related polymorphisms at the TOX3/LOC643714 locus associated with lung cancer risk in a Han Chinese population.
  Jiang Chaowen, et al. Oncotarget 2016 7
• Comparing overall survival between first generation EGFR-TKIs and chemotherapy in lung cancer patients with Del19/L858R.
  Deng Wei, et al. Chinese journal of cancer research = Chung-kuo yen cheng yen chiu 2016 6 (3) 339-47
• Total and mutated EGFR quantification in cell-free DNA from non-small cell lung cancer patients detects tumor heterogeneity and presents prognostic value.
  Alegre E, et al. Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine 2016 7
• TGF-?1 rs1982073 polymorphism contributes to radiation pneumonitis in lung cancer patients: a meta-analysis.
  Shen Ze-Tian, et al. Journal of cellular and molecular medicine 2016 7
• Clinical efficacy of first-generation EGFR-TKIs in patients with advanced non-small-cell lung cancer harboring EGFR exon 20 mutations.
  Chen Dan, et al. OncoTargets and therapy 2016 0 4181-6
• PD-L1 expression in non-small cell lung cancer: Correlations with genetic alterations.
  Scheel Andreas H, et al. Oncoimmunology 2016 5 (5) e1131379
• The genetic variations in DNA repair genes ERCC2 and XRCC1 were associated with the overall survival of advanced non-small-cell lung cancer patients.
  Wang Suhan, et al. Cancer medicine 2016 7
• A randomized phase 2 study comparing the combination of ficlatuzumab and gefitinib with gefitinib alone in Asian patients with advanced stage pulmonary adenocarcinoma.
  Kam Mok Tony Shu, et al. Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer 2016 7
• ALK positivity on pleuroscopic pleural biopsy in lung adenocarcinoma.
  Vaidya Preyas J, et al. Journal of cancer research and therapeutics 0 0 (2) 1090-2
• An efficient method to genotype the polymorphisms of cholinergic nicotinic receptor subunit genes and their associations with COPD onset risk.
  Zhao Zhuxiang, et al. Experimental lung research 2016 6 (5) 267-74

• CDC Information (2)
• CDC-Authored Pub (8)

• Human (30)
• Pathogen (0)

• Human (3883)
• Pathogen (0)

• Human (63)
• Pathogen (0)

• Guidelines (8)
• Tier Table (4)
• Synthesis (11)

• Huamn (4)
• Pathogen (0)

Relevant Resources

• Cancer Genomics and Epidemiology Navigator (CGEN)
• Genetics and Genomics Competencies Center (G2C2)
• NIH Genetic Testing Registry
• NIH MedGen Database
• Online Mendelian Inheritance in Man (OMIM)
• PharmGKB